Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment
Keywords: AP-1; activator protein-1 transcription factor; API; active pharmaceutical ingredient; BM; basement membrane; BALF; bronchoalveolar lavage fluid; BALT; broncho-associated lymphoid tissue; BCS; biopharmaceutical classification system; BOS; bronchiolitis ob